Instrument Business Outlook

1. Market profile: bioanalyzers.
Bioanalyzers are based on decades old technology, but are experiencing a rebirth in demand thanks to the burgeoning biotechnology industry. Not to be confused with ...
(PERIODICAL ARTICLE)

2. The European Commission funded a two-year cooperative research project to...
The European Commission funded a two-year cooperative research project to develop Array Based Sequencing-by-Synthesis technology. Consortium companies include: QUIAtech AB, a developer of DNA and ...
(PERIODICAL ARTICLE)

3. VisiGen Biotechnologies received a three-year, $4.2 million grant and...
VisiGen Biotechnologies received a three-year, $4.2 million grant and Nanofluidics received a three-year, $6.6 million grant from the US National Human Genome Research Institute to ...
(PERIODICAL ARTICLE)

4. ABB.
Effective January 1, 2006, ABB will replace its two core divisions with five business areas, including a Process Automation unit, which will be based in ...
(PERIODICAL ARTICLE)

5. In July, Techne's R&D Systems subsidiary acquired Fortron Bio Science, a...
In July, Techne's R&D Systems subsidiary acquired Fortron Bio Science, a developer and manufacturer of antibodies, antigens and other biological reagents, and BiosPacific, a supplier ...
(PERIODICAL ARTICLE)

6. As part of a program to consolidate a number of functional areas under one...
As part of a program to consolidate a number of functional areas under one management structure for its Chemicon and Upstate units, Serologicals plans to ...
(PERIODICAL ARTICLE)

7. Discrete analyzers: a force in environmental analysis.
For nearly two decades now, discrete analyzers have played a major role in the evolution and automation of clinical laboratory analysis. Offering faster, more reproducible ...
(PERIODICAL ARTICLE)

8. EU: pressured by the European Commission, the European Investment Bank...
EU: Pressured by the European Commission, the European Investment Bank (EIB) will attempt to address the financial gap faced by EU biotech firms. A controversial ...
(PERIODICAL ARTICLE)

9. Pharmaceutical: Theranostics, the coupling of diagnostics and therapeutics,...
Pharmaceutical: Theranostics, the coupling of diagnostics and therapeutics, could replace the blockbuster drug model. Theranostics is mostly in the R&D stage as scientists seek molecular ...
(PERIODICAL ARTICLE)

10. Academia: the Association of University Technology Managers' (AUTM) "AUTM...
Academia: The Association of University Technology Managers' (AUTM) "AUTM U.S. Licensing Survey: FY: 2004" reported almost 25% growth in technology transfer as 462 new companies ...
(PERIODICAL ARTICLE)